Key result
MULTI-LINK VISION bare-metal stent shows similar TLR rates versus PRO-Kinetic stent.
Why the study?
Does the MULTI-LINK VISION stent improve clinical outcomes compared to the PRO-Kinetic stent in patients with coronary artery disease selected for bare-metal stent implantation?
Cohort (n=1,176)
No
Does the MULTI-LINK VISION stent improve clinical outcomes compared to the PRO-Kinetic stent in patients with coronary artery disease selected for bare-metal stent implantation?
Answers are grounded in this paper and cite their sources.
In selected patients, new-generation thin-strut bare-metal stents (MULTI-LINK VISION and PRO-Kinetic) provide acceptable and comparable long-term clinical outcomes.
BACKGROUND: Despite widespread penetration of drug-eluting stents (DES) in clinical practice, a relevant percentage of patients with coronary artery disease are still treated with bare-metal stents (BMS). Contemporary BMS, however, are less well investigated and comparative data on clinical outcome are lacking. METHODS AND RESULTS: This single-center registry aimed to assess characteristics and outcome of patients treated with 2 different new-generation cobalt-chromium BMS, the MULTI-LINK VISION and PRO-Kinetic stents. During the study, adopted criteria for BMS selection were: (1) limited compliance to dual antiplatelet therapy, (2) ST-elevation myocardial infarction (MI) or saphenous vein graft (SVG) interventions, and (3) noncomplex lesions located either in the right coronary artery or in the nonproximal segments of the left coronary artery. During a 24-month period 1,176 patients were treated with the VISION (n = 438) or PRO-Kinetic stent (n = 738). Median duration of follow-up was 549.5 and 528.5 days, respectively. Target lesion revascularization (TLR) and target vessel revascularization were numerically lower in the VISION group (10.4 vs. 12.3% and 11.9 vs. 15.2%, P = 0.24 and 0.11). Death (4.1 vs. 4.3%, P = 0.85), MI (2 vs. 2.3%, P = 0.78), and ARC definite stent thrombosis (0.5 vs. 0.5%, P = 0.84) were similar. By multivariate analysis, variables associated with TLR were SVG interventions (HR 2.21, 95% CI 1.26-3.86), total stent length (HR 1.01, 95% CI 1.00-1.02), and smoking (HR 1.51, 95% CI 1.05-2.16). CONCLUSION: In the DES era, the use of last-generation thin-strut BMS in selected patients is associated with acceptable clinical outcome, with similar clinical results for both the MULTI-LINK VISION and PRO-Kinetic stents.
No takes yet. Share an insight, caveat, or question.
Abdel‐Wahab et al. (2011) conducted a cohort in Coronary artery disease (n=1,176). MULTI-LINK VISION stent vs. PRO-Kinetic stent was evaluated on Target lesion revascularization (TLR) (p=0.24). The MULTI-LINK VISION bare-metal stent was associated with similar rates of target lesion revascularization compared to the PRO-Kinetic stent.
Synapse has enriched 10 related papers. Consider them for comparative context: